CD274 and neoplasm: The expression of immunoregulatory genes (e.g., Cd274, Pdcd1lg2, Cd200) as well as genes associated with Th2 responses and IL‐4 signalling limited the ability of cDCs to prime CTL and Th1 responses, resulting in increased tumour burden in mice [44].